Previous close | 6.96 |
Open | 7.05 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 7.05 - 7.05 |
52-week range | 6.37 - 7.68 |
Volume | |
Avg. volume | 2,812 |
Market cap | 7.535B |
Beta (5Y monthly) | 0.59 |
PE ratio (TTM) | 50.36 |
EPS (TTM) | 0.14 |
Earnings date | 08 May 2024 |
Forward dividend & yield | 0.28 (4.03%) |
Ex-dividend date | 28 Dec 2023 |
1y target est | N/A |
TOKYO, April 19, 2024--The AGC Group had announced that it will donate 3 million yen to help those affected by the eastern Taiwan Earthquake.
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.’s Yokohama Technical Center in Japan. The new site is a part of the CDMO’s strategic growth strategy to create more high-quali